Tokyo, Japan

Masaaki Terada

USPTO Granted Patents = 8 


Average Co-Inventor Count = 4.7

ph-index = 2

Forward Citations = 29(Granted Patents)


Location History:

  • Tokyo, JP (1997 - 2006)
  • Tokyo-to, JP (2014)

Company Filing History:


Years Active: 1997-2014

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Masaaki Terada: Innovator in Nucleic Acid Transfer Technologies

Introduction

Masaaki Terada is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of gene therapy, holding a total of 8 patents. His work focuses on methods that enhance the efficiency of nucleic acid transfer into cells, which is crucial for advancing therapeutic techniques.

Latest Patents

Among his latest patents, one notable invention is a method of promoting nucleic acid transfer. This invention provides a means for efficiently transferring a desired nucleic acid into a cell using a complex that includes collagen or a collagen derivative. Another significant patent is directed towards the stability of formulations useful for gene therapy. This invention involves the addition of at least one saccharide, one non-hydrophobic amino acid, or one organic acid with multiple carboxyl groups to a gene formulation, ensuring its stability during preparation and preservation.

Career Highlights

Masaaki Terada has worked with esteemed organizations such as the National Cancer Center and Koken Company, Limited. His experience in these institutions has allowed him to develop innovative solutions that address critical challenges in gene therapy.

Collaborations

Throughout his career, Terada has collaborated with notable colleagues, including Takahiro Ochiya and Koichi Igarashi. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Masaaki Terada's contributions to nucleic acid transfer technologies have positioned him as a key figure in the field of gene therapy. His innovative patents and collaborations reflect his commitment to advancing medical science and improving therapeutic outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…